X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
45
PharmaCompass offers a list of Diphenhydramine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Diphenhydramine Hydrochloride manufacturer or Diphenhydramine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Diphenhydramine Hydrochloride manufacturer or Diphenhydramine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Diphenhydramine Hydrochloride API Price utilized in the formulation of products. Diphenhydramine Hydrochloride API Price is not always fixed or binding as the Diphenhydramine Hydrochloride Price is obtained through a variety of data sources. The Diphenhydramine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Diphenhydramine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Diphenhydramine Hydrochloride, including repackagers and relabelers. The FDA regulates Diphenhydramine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Diphenhydramine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Diphenhydramine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Diphenhydramine Hydrochloride supplier is an individual or a company that provides Diphenhydramine Hydrochloride active pharmaceutical ingredient (API) or Diphenhydramine Hydrochloride finished formulations upon request. The Diphenhydramine Hydrochloride suppliers may include Diphenhydramine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Diphenhydramine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Diphenhydramine Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Diphenhydramine Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Diphenhydramine Hydrochloride DMFs exist exist since differing nations have different regulations, such as Diphenhydramine Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Diphenhydramine Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Diphenhydramine Hydrochloride USDMF includes data on Diphenhydramine Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Diphenhydramine Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Diphenhydramine Hydrochloride suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Diphenhydramine Hydrochloride Drug Master File in Japan (Diphenhydramine Hydrochloride JDMF) empowers Diphenhydramine Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Diphenhydramine Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Diphenhydramine Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Diphenhydramine Hydrochloride suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Diphenhydramine Hydrochloride Drug Master File in Korea (Diphenhydramine Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Diphenhydramine Hydrochloride. The MFDS reviews the Diphenhydramine Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Diphenhydramine Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Diphenhydramine Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Diphenhydramine Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Diphenhydramine Hydrochloride suppliers with KDMF on PharmaCompass.
A Diphenhydramine Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Diphenhydramine Hydrochloride Certificate of Suitability (COS). The purpose of a Diphenhydramine Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Diphenhydramine Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Diphenhydramine Hydrochloride to their clients by showing that a Diphenhydramine Hydrochloride CEP has been issued for it. The manufacturer submits a Diphenhydramine Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Diphenhydramine Hydrochloride CEP holder for the record. Additionally, the data presented in the Diphenhydramine Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Diphenhydramine Hydrochloride DMF.
A Diphenhydramine Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Diphenhydramine Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Diphenhydramine Hydrochloride suppliers with CEP (COS) on PharmaCompass.
A Diphenhydramine Hydrochloride written confirmation (Diphenhydramine Hydrochloride WC) is an official document issued by a regulatory agency to a Diphenhydramine Hydrochloride manufacturer, verifying that the manufacturing facility of a Diphenhydramine Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Diphenhydramine Hydrochloride APIs or Diphenhydramine Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Diphenhydramine Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Diphenhydramine Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Diphenhydramine Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Diphenhydramine Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Diphenhydramine Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Diphenhydramine Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Diphenhydramine Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Diphenhydramine Hydrochloride suppliers with NDC on PharmaCompass.
Diphenhydramine Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Diphenhydramine Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Diphenhydramine Hydrochloride GMP manufacturer or Diphenhydramine Hydrochloride GMP API supplier for your needs.
A Diphenhydramine Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Diphenhydramine Hydrochloride's compliance with Diphenhydramine Hydrochloride specifications and serves as a tool for batch-level quality control.
Diphenhydramine Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Diphenhydramine Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Diphenhydramine Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Diphenhydramine Hydrochloride EP), Diphenhydramine Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Diphenhydramine Hydrochloride USP).
Market Place
